Cabotegravir – September 2023

• Brand names:
  • Apretude®
• Pharmaceutical Company:
  • ViiV Healthcare Pty Ltd
• Condition/Indication: Pre-exposure prophylaxis of HIV infection
• Meeting Date: September 2023
• Public Summary Document (PSD) July 2023 - September 2023 PBAC Meetings - (PDF 1.3MB)
• Public Summary Document (PSD) July 2023 - September 2023 PBAC Meetings - (Word 273KB)

Related Public Summary Documents

Cabotegravir – July 2023